# The US Food and Drug Administration approves the first gene therapy for inherited hearing loss.

*biotech · news · 2026-04-23 · Cable News Network*

## Key points

- FDA approved Regeneron's Otarmeni, the first gene therapy for inherited hearing loss.
- Regeneron will provide Otarmeni free to US patients despite typical million-dollar gene therapy prices.
- In a trial, 16 of 20 children had improved hearing within five months after Otarmeni treatment.
- Otarmeni is administered with a procedure similar to cochlear implant surgery and showed no major safety issues.

**Companies:** Regeneron
**Countries:** United States

[Read the full story on Cable News Network](https://edition.cnn.com/health/fda-approves-first-gene-therapy-for-inherited-deafness-shown-to-restore-hearing-for-children-with-rare-condition)

---

Canonical: https://newsio.io/n/7e6d8fed-93fd-4902-afe3-f0d4b4e2bf26/the-us-food-and-drug-administration-approves-the-first-gene-therapy-for-inherite
Summarized by Newsio from Cable News Network. https://newsio.io/how-it-works